BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Asbaghi O, Ghanbari N, Shekari M, Reiner Ž, Amirani E, Hallajzadeh J, Mirsafaei L, Asemi Z. The effect of berberine supplementation on obesity parameters, inflammation and liver function enzymes: A systematic review and meta-analysis of randomized controlled trials. Clin Nutr ESPEN 2020;38:43-9. [PMID: 32690176 DOI: 10.1016/j.clnesp.2020.04.010] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
Number Citing Articles
1 Zamani M, Ashtary-Larky D, Hafizi N, Naeini F, Rezaei Kelishadi M, Clark CCT, Davoodi SH, Asbaghi O. The effect of grape products on liver enzymes: A systematic review and meta-analysis of randomized controlled trials. Phytother Res 2022. [PMID: 36264051 DOI: 10.1002/ptr.7653] [Reference Citation Analysis]
2 Zamani M, Zarei M, Nikbaf-Shandiz M, Hosseini S, Shiraseb F, Asbaghi O. The effects of berberine supplementation on cardiovascular risk factors in adults: A systematic review and dose-response meta-analysis. Front Nutr 2022;9:1013055. [PMID: 36313096 DOI: 10.3389/fnut.2022.1013055] [Reference Citation Analysis]
3 Er H, Gobel P. Polikistik Over Sendromunun Beslenme Tedavisinde Berberinin Yeri. AvrasyaSBD 2022. [DOI: 10.53493/avrasyasbd.1085272] [Reference Citation Analysis]
4 Guo J, Chen H, Zhang X, Lou W, Zhang P, Qiu Y, Zhang C, Wang Y, Liu WJ. The Effect of Berberine on Metabolic Profiles in Type 2 Diabetic Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Oxid Med Cell Longev 2021;2021:2074610. [PMID: 34956436 DOI: 10.1155/2021/2074610] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
5 Rauf A, Abu-Izneid T, Khalil AA, Imran M, Shah ZA, Emran TB, Mitra S, Khan Z, Alhumaydhi FA, Aljohani ASM, Khan I, Rahman MM, Jeandet P, Gondal TA. Berberine as a Potential Anticancer Agent: A Comprehensive Review. Molecules 2021;26:7368. [PMID: 34885950 DOI: 10.3390/molecules26237368] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 32.0] [Reference Citation Analysis]
6 Patel P. A bird's eye view on a therapeutically ‘wonder molecule’: Berberine. Phytomedicine Plus 2021;1:100070. [DOI: 10.1016/j.phyplu.2021.100070] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
7 Senesi P, Ferrulli A, Luzi L, Terruzzi I. Diabetes Mellitus and Cardiovascular Diseases: Nutraceutical Interventions Related to Caloric Restriction. Int J Mol Sci 2021;22:7772. [PMID: 34360538 DOI: 10.3390/ijms22157772] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
8 Khashayar A, Bahari Z, Elliyeh M, Ghasemi M. Therapeutic Effects of Berberine in Metabolic Diseases and Diabetes Mellitus. Rev Bras Farmacogn 2021;31:272-81. [DOI: 10.1007/s43450-021-00159-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
9 Ye Y, Liu X, Wu N, Han Y, Wang J, Yu Y, Chen Q. Efficacy and Safety of Berberine Alone for Several Metabolic Disorders: A Systematic Review and Meta-Analysis of Randomized Clinical Trials. Front Pharmacol 2021;12:653887. [PMID: 33981233 DOI: 10.3389/fphar.2021.653887] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 14.0] [Reference Citation Analysis]
10 Rysz J, Franczyk B, Kujawski K, Sacewicz-Hofman I, Ciałkowska-Rysz A, Gluba-Brzózka A. Are Nutraceuticals Beneficial in Chronic Kidney Disease? Pharmaceutics 2021;13:231. [PMID: 33562154 DOI: 10.3390/pharmaceutics13020231] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Bousquet J, Cristol JP, Czarlewski W, Anto JM, Martineau A, Haahtela T, Fonseca SC, Iaccarino G, Blain H, Fiocchi A, Canonica GW, Fonseca JA, Vidal A, Choi HJ, Kim HJ, Le Moing V, Reynes J, Sheikh A, Akdis CA, Zuberbier T; ARIA group. Nrf2-interacting nutrients and COVID-19: time for research to develop adaptation strategies. Clin Transl Allergy 2020;10:58. [PMID: 33292691 DOI: 10.1186/s13601-020-00362-7] [Cited by in Crossref: 28] [Cited by in F6Publishing: 31] [Article Influence: 14.0] [Reference Citation Analysis]